Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
Abstract Traditional cancer treatments use nonspecific drugs and monoclonal antibodies to target tumor cells. Chimeric antigen receptor (CAR)-T cell therapy, however, leverages the immune system's T-cells to recognize and attack tumor cells. T-cells are isolated from patients and modified to ta...
Main Authors: | Gunjan Dagar, Ashna Gupta, Tariq Masoodi, Sabah Nisar, Maysaloun Merhi, Sheema Hashem, Ravi Chauhan, Manisha Dagar, Sameer Mirza, Puneet Bagga, Rakesh Kumar, Ammira S. Al-Shabeeb Akil, Muzafar A. Macha, Mohammad Haris, Shahab Uddin, Mayank Singh, Ajaz A. Bhat |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04292-3 |
Similar Items
-
Correction: Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
by: Gunjan Dagar, et al.
Published: (2023-08-01) -
Ubiquitin specific peptidase 37 and PCNA interaction promotes osteosarcoma pathogenesis by modulating replication fork progression
by: Ravi Chauhan, et al.
Published: (2023-04-01) -
Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges
by: Dennis Christoph Harrer, et al.
Published: (2023-11-01) -
Nanobody Based Dual Specific CARs
by: Stijn De Munter, et al.
Published: (2018-01-01) -
Harnessing Dendritic Cells for Tumor Antigen Presentation
by: Stefan Nierkens, et al.
Published: (2011-04-01)